Back

Rapidly progressive ATTR-CM could be fuelling heart failure: Cardiac and extracardiac red flags to look out for

17 May 2025 (15:18 - 15:23)
Organised by: Logo
Congress Presentation Part of: ACT FAST for ATTR-CM: early clues in heart failure to raise clinical suspicion Cardiac Amyloidosis HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Olivier Lairez

University Hospital of Toulouse, Toulouse (France)

6 More presentations in this session

Presentation thumbnail
Introduction
Professor A. Ristic (Belgrade, RS)
Slides
Presentation thumbnail
ATTR-CM Pathophysiology: Toxic misfolded TTR is at the 'heart' of the issue
Doctor A. Porcari (Trieste, IT)
Slides
Presentation thumbnail
The ATTR-CM patient profile of today and how this has evolved
Doctor A. Porcari (Trieste, IT)
Slides
Presentation thumbnail
Harnessing imaging insights to accelerate an ATTR-CM diagnosis
Professor O. Lairez (Toulouse, FR)
Slides
Presentation thumbnail
Q&A
Slides

Access the full session

Session thumbnail
ACT FAST for ATTR-CM: early clues in heart failure to raise clinical suspicion
Video

The Event

Event poster

Heart Failure 2025

17 May 2025 15:18 CET
You may be interested in
thumbnail
Congress Session
ATTRibutes of change: advances in treating and monitoring ATTR-CM
17 May 2025
thumbnail
Congress Presentation
Red-flag signs and symptoms of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy in the TTRACK study
21 May 2023
thumbnail
Congress Presentation
Rapid stiffening as a loud warning: a case of light-chain cardiac amyloidosis presenting with isolated diastolic collapse
12 December 2025
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources